SYNH Syneos Health Inc

Price (delayed)

$85.76

Market cap

$8.94B

P/E Ratio

45.14

Dividend/share

N/A

EPS

$1.9

Enterprise value

$11.84B

Sector: Healthcare
Industry: Diagnostics & Research

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to ...

Highlights

Syneos Health's equity has increased by 9% YoY
Syneos Health's gross margin has increased by 6% YoY
The P/E is 30% above the last 4 quarters average of 34.4
Syneos Health's quick ratio has decreased by 12% YoY

Key stats

What are the main financial stats of SYNH
Market
Shares outstanding
104.29M
Market cap
$8.94B
Enterprise value
$11.84B
Valuations
Price to earnings (P/E)
45.14
Price to book (P/B)
2.76
Price to sales (P/S)
2
EV/EBIT
39.82
EV/EBITDA
22.7
EV/Sales
2.65
Earnings
Revenue
$4.46B
EBIT
$297.37M
EBITDA
$521.55M
Free cash flow
$541.88M
Per share
EPS
$1.9
Free cash flow per share
$5.2
Book value per share
$31.03
Revenue per share
$42.78
TBVPS
$21.85
Balance sheet
Total assets
$7.95B
Total liabilities
$4.72B
Debt
$3.16B
Equity
$3.24B
Working capital
$142.09M
Liquidity
Debt to equity
0.98
Current ratio
1.09
Quick ratio
1.02
Net debt/EBITDA
5.55
Margins
EBITDA margin
11.7%
Gross margin
23.4%
Net margin
4.4%
Operating margin
6.8%
Efficiency
Return on assets
2.6%
Return on equity
6.3%
Return on invested capital
8.5%
Return on capital employed
4.6%
Return on sales
6.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SYNH stock price

How has the Syneos Health stock price performed over time
Intraday
0.6%
1 week
3.55%
1 month
7.82%
1 year
58.96%
YTD
25.88%
QTD
13.07%

Financial performance

How have Syneos Health's revenue and profit performed over time
Revenue
$4.46B
Gross profit
$1.04B
Operating income
$305.19M
Net income
$197.94M
Gross margin
23.4%
Net margin
4.4%
SYNH's operating margin is up by 24% year-on-year and by 3% since the previous quarter
The company's operating income rose by 17% YoY and by 4.1% QoQ
Syneos Health's net margin has increased by 7% YoY
Syneos Health's gross margin has increased by 6% YoY

Growth

What is Syneos Health's growth rate over time

Valuation

What is Syneos Health stock price valuation
P/E
45.14
P/B
2.76
P/S
2
EV/EBIT
39.82
EV/EBITDA
22.7
EV/Sales
2.65
The P/E is 30% above the last 4 quarters average of 34.4
Syneos Health's EPS has increased by 2.7% QoQ
SYNH's price to book (P/B) is 31% higher than its last 4 quarters average of 2.1 but 19% lower than its 5-year quarterly average of 3.4
Syneos Health's equity has increased by 9% YoY
The price to sales (P/S) is 42% higher than the 5-year quarterly average of 1.4 and 33% higher than the last 4 quarters average of 1.5
SYNH's revenue is down by 5% YoY

Efficiency

How efficient is Syneos Health business performance
Syneos Health's return on sales has increased by 10% YoY
Syneos Health's return on equity has decreased by 6% YoY
Syneos Health's return on assets has increased by 4% QoQ
SYNH's ROIC is up by 2.4% from the previous quarter and by 2.4% YoY

Dividends

What is SYNH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SYNH.

Financial health

How did Syneos Health financials performed over time
The total assets is 69% higher than the total liabilities
Syneos Health's quick ratio has decreased by 12% YoY
The company's current ratio fell by 11% YoY
Syneos Health's debt is 2.3% lower than its equity
Syneos Health's equity has increased by 9% YoY
SYNH's debt to equity is down by 9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.